Sorry, you need to enable JavaScript to visit this website.

EUCRISA (crisaborole) Patient Counseling Information

17 PATIENT COUNSELING INFORMATION

Advise the patient or caregivers to read the FDA-approved patient labeling (Patient Information).

Hypersensitivity Reactions

Advise patients to discontinue EUCRISA and seek medical attention immediately if signs or symptoms of hypersensitivity occur [see Warnings and Precautions (5.1)].

Administration Instructions

Advise patients or caregivers that EUCRISA is for external use only and is not for ophthalmic, oral, or intravaginal use.

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No